| 영문 | oxygen | 한글 | 산소 |
|---|---|---|---|
| 설명 | 폐로 들어가 모세혈관을 통해 적혈구내로 들어간다. 적혈구내의 혈색소의 역할로 신체내 모든 조직세포에 전해지며, 인체대사작용에 필수적인 기체이다. |
||
| 영문 | intermittent positive pressure breathing(IPPB) | 한글 | 간헐적양압호흡 |
|---|---|---|---|
| 설명 | 폐를 팽창시키기 위하여 대기압보다 높은 압력을 이용하는 인공호흡법이다. 신생아 무기폐의 치료나 만성 폐쇄성 호흡기 질환의 급성 악화시, 진단을 위한 가래의 배출을 위하여, 또는 약제의 흡입에 사용하고 있다. 합병증으로 공기가슴증이나 심박출량의 감소가 올 수 있다. |
||
| 영문 | pulse pressure | 한글 | 맥박압 |
|---|---|---|---|
| 설명 | 수축기 혈압과 확장기 혈압의 차이. mmHg로 표시한다. 심장의 수축력, 동맥 내 혈류량, 동맥벽의 긴장도에 영향을 받는다. 정상치는 수축기 혈압의 1/3, 또는 확장기 혈압의 1/2이다. 60mmHg이상을 대맥이라고 하며, 대동맥판막 폐쇄부족증, 갑상샘항진증, 동맥경화증, 혈압이 상승할 때 심장비대, 고열 등에서 볼 수 있다. 20mmHg 이하를 소맥이라고 하며, 급성 심근경색에 의한 좌심실 수축력 저하, 대동맥판막 협착등에서 볼 수 있다. 한편 맥압의 1/3에 확장기 혈압을 더한 것을 평균혈압이라고 한다. |
||
| 영문 | osmotic pressure | 한글 | 삼투압 |
|---|---|---|---|
| 설명 | 삼투라는 현상은 일정 크기 이하의 물질은 통과시키고 그 이상의 크기를 가진 물질은 통과 시키지 못하게 하는 막(반투막)을 사이에 두고 양쪽에 그 막을 투과하지 못하는 물질의 농도가 차이가 날 때 발생하는 것으로 막을 통과할 수 있는 물질이 막 양쪽의 통과 할 수 없는 물질의 농도를 같게 하는 방향으로 움직이는 것을 말한다. |
||
| 영문 | systolic pressure | 한글 | 수축기압 |
|---|---|---|---|
| 설명 | 심활동력, 동맥벽의 탄력성, 혈액량, 혈액의 점성 등에 의하여 결정되는 혈액의 동맥벽에 미치는 압력으로서, 최고혈압은 왼심실로부터 박출이 끝나기 직전에 생기는 압을 말하고 최대 혈압 또는 수축기혈압이라 부른다. 최소혈압은 왼심실의 확장이 끝나는 시기에 생기는 혈압을 말하며 최소혈압 또는 확장기혈압이라고 부른다. 평균혈압은 동맥내압의 평균치를 말하며, 기초혈압은 절대안정 상태에서 측정한 혈압을 말한다. |
||
| PaO2 | partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood |
|---|---|
| MAP | malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ... |
| PP | diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa... |
| OAP | Office of Adolescent Pregnancy; old age pension, old age pensioner; ophthalmic artery pressure; oste... |
| OPP | osmotic pressure of plasma; oxygen partial pressure |
| PO2 | Partial oxygen pressure |
|---|---|
| TcPO2 | Transcutaneous partial pressure of oxygen |
| PO2 | pressure of oxygen |
| PaO2 | pressure of arterial oxygen |
| PCO2 | pressure , carbon dioxide pressure |
pressure necrosis
| alactic oxygen debt | That part of the oxygen debt that is not lactacid oxygen debt; during recovery, stores of ATP and creatine phosphate must be replenished by oxidative metabolism, and a small amount of oxygen is also needed to restore the normal oxyhemoglobin levels throughout the circulating blood. (05 Mar 2000) |
|---|---|
| alveolar-arterial oxygen difference | The difference or gradient between the partial pressure of oxygen in the alveolar spaces and the arterial blood: P(A-a)02. Normally in young adults this value is less than 20 mm Hg. See: alveolar gas equation. (05 Mar 2000) |
| arteriovenous oxygen difference | <physiology> The difference in the oxygen content (in ml per 100 ml blood) between arterial and venous blood. (05 Mar 2000) |
| biochemical oxygen demand | The amount of oxygen aerobicorganisms need to carry out oxidative metabolism in watercontaining organic matter, such as sewage. (09 Oct 1997) |
| carbon-oxygen ligases | <enzyme> Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. Registry number: EC 6.1 (12 Dec 1998) |
| carbon-oxygen lyases | <enzyme> Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation. Registry number: EC 4.2 (12 Dec 1998) |
| reactive oxygen species | Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development. (12 Dec 1998) |
| chemical oxygen demand | The amount of dissolved oxygen required to combine with chemicals in wastewater. A measure of the oxygen equivalent of that portion of organic matter that is susceptible to oxidation by a strong chemical oxidizing agent. (05 Dec 1998) |
| rubredoxin-oxygen oxidoreductase | <enzyme> Contains fad and a new type of haem; site of oxygen reduction to water by desulfovibrio gigas coupled with NADH oxidation Registry number: EC 1.9.3.- Synonym: rubredoxin oxidase (26 Jun 1999) |
| phosphorus-oxygen lyases | <enzyme> Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation. Registry number: EC 4.6 (12 Dec 1998) |
| critical dissolved oxygen concentration | <biology> The minimum concentration of oxygen in the water needed for the growth of a culture which has been submerged, where oxygen is the limiting factor to the growth of the culture. (09 Oct 1997) |
| heavy oxygen | A stable oxygen isotope making up 0.20% of natural oxygen; used in mass spectrometry and in NMR studies of tissue. Synonym: heavy oxygen. (05 Mar 2000) |
| home oxygen therapy | A form of oxygen that is typically delivered via nasal cannula. Commonly provided to those with severe heart or lung disease. See: chronic obstructive pulmonary disease. (27 Sep 1997) |
| hyperbaric oxygen | High pressure oxygen, oxygen at a pressure greater than 1 atmosphere. See: hyperbaric oxygenation. Singlet oxygen, an excited or higher energy form of oxygen characterised by the spin of a pair of electrons in opposite directions, whereas electron spin is unidirectional in normal molecular oxygen Because of its great reactivity, singlet oxygen is a probable intermediate in most photo-oxidation reactions. Although it exists for no more than 0.1 sec, it may react with atmospheric pollutants to foster smog formation and may have harmful biological effects. Triplet oxygen, the normal unexcited state of O2 in the atmosphere, in which the unpaired pair of electrons are so displaced that their magnetic fields are oriented in the same direction, resulting in paramagnetism; each of the heat-generated spectral lines of such oxygen can be split by a magnetic field into a triplet. Compare: singlet oxygen. (05 Mar 2000) |
| hyperbaric oxygen therapy | <physiology> A pressurised chamber that allows for the delivery of oxygen in higher concentrations for therapeutic benefit. Useful in the treatment of severe burns, peripheral vascular disease, carbon monoxide poisoning and decompression illness. (04 Mar 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|